We are live on ! Find out more
BOCH

Blue Owl Capital Holdings Portfolio holdings

AUM $372M
1-Year Est. Return 78.25%
This Fund
S&P 500
This Quarter Est. Return
+13.94%
1 Year Est. Return
+78.25%
3 Year Est. Return
+112.77%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$518M
AUM Growth
+$159M
Cap. Flow
+$131M
Cap. Flow %
25.19%
Top 10 Hldgs %
65.06%
Holding
140
New
98
Increased
11
Reduced
9
Closed
3

Top Buys

Rank Stock Value
1
NCDL icon
Nuveen Churchill Direct Lending
NCDL
+$70.6M
2
TQQQ icon
ProShares UltraPro QQQ
TQQQ
+$22.3M
3
CNDT icon
Conduent
CNDT
+$12.3M
4
HLLY icon
Holley
HLLY
+$8.52M
5
GAQ
Generation Asia I Acquisition Limited Class A Ordinary Shares
GAQ
+$5.23M

Top Sells

Rank Stock Value
1
TOST icon
Toast
TOST
+$8.31M
2
VKTX icon
Viking Therapeutics
VKTX
+$5.57M
3
RARE icon
Ultragenyx Pharmaceutical
RARE
+$5.35M
4
TRML
Tourmaline Bio
TRML
+$3.09M
5
MLYS icon
Mineralys Therapeutics
MLYS
+$3.08M

Sector Composition

Rank Sector Weight
1 Healthcare 53.22%
2 Financials 20.04%
3 Technology 17.47%
4 Consumer Discretionary 1.45%
5 Industrials 1.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BNAIW
101
Brand Engagement Network Warrant
BNAIW
$2.16M
$2.4K ﹤0.01%
+34,303
New +$2.68K
MNTN.WS
102
DELISTED
Everest Consolidator Acquisition Corporation Warrants, each whole warrant exercisable for one share of Class A Common Stock, at an exercise price of $11.50
MNTN.WS
$2.25K ﹤0.01%
+75,000
New +$7.57K
CEROW
103
DELISTED
CERo Therapeutics Warrants
CEROW
$2.25K ﹤0.01%
+224,930
New +$3.73K
NKGNW
104
DELISTED
NKGen Biotech, Inc. Warrants
NKGNW
$2.1K ﹤0.01%
+30,000
New +$2.68K
TVGNW icon
105
Tevogen Inc. Warrant
TVGNW
$933K
$2K ﹤0.01%
+200,000
New +$3.94K
ASBPW
106
Aspire Biopharma Warrant
ASBPW
$2K ﹤0.01%
+50,000
New +$2.38K
PLAOW
107
DELISTED
Patria Latin American Opportunity Acquisition Corp. Warrant
PLAOW
$2K ﹤0.01%
+50,000
New +$1.75K
GAQ
108
DELISTED
Generation Asia I Acquisition Limited Class A Ordinary Shares
GAQ
$1.61K ﹤0.01%
+465,677
New +$5.23M
BAERW icon
109
Bridger Aerospace Warrant
BAERW
$11.6M
$1.5K ﹤0.01%
+25,000
New +$1.95K
DAVEW icon
110
Dave Inc Warrants
DAVEW
$13.5M
$1.44K ﹤0.01%
+28,750
New +$1.08K
IVCBW
111
DELISTED
Investcorp Europe Acquisition Corp I Warrant
IVCBW
$1.38K ﹤0.01%
+137,500
New +$5.09K
UHGWW
112
DELISTED
United Homes Group Warrant
UHGWW
$1.27K ﹤0.01%
+1,250
New +$1K
AMBP.WS
113
DELISTED
Ardagh Metal Packaging Warrants
AMBP.WS
$1.2K ﹤0.01%
+20,000
New +$794
PDYNW icon
114
Palladyne AI Corp Warrants
PDYNW
$169K
$1.05K ﹤0.01%
+35,000
New +$984
WEL.WS
115
DELISTED
Integrated Wellness Acquisition Corp Redeemable Warrants
WEL.WS
$1K ﹤0.01%
+50,000
New +$1.07K
ONYXW
116
DELISTED
Onyx Acquisition Co. I Warrant
ONYXW
$1K ﹤0.01%
+100,000
New +$1.89K
MCAAW
117
DELISTED
Mountain & Co. I Acquisition Corp. Warrant
MCAAW
$750 ﹤0.01%
+75,000
New +$3.08K
BYNO
118
DELISTED
byNordic Acquisition Corporation Class A Common Stock
BYNO
$549 ﹤0.01%
+91,429
New +$1.04M
WBX.WS
119
DELISTED
Wallbox N.V. Warrants, each warrant to purchase one Class A Ordinary Share
WBX.WS
$500 ﹤0.01%
+5,000
New +$491
PNST.WS
120
DELISTED
Pinstripes Holdings, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
PNST.WS
$500 ﹤0.01%
+50,000
New +$2.83K
XBPEW
121
XBP Europe Holdings Warrant
XBPEW
$496 ﹤0.01%
+24,778
New +$800
HLLY.WS
122
DELISTED
Holley Inc Warrants
HLLY.WS
$400 ﹤0.01%
+6,666
New +$526
SLXNW
123
Silexion Therapeutics Warrant
SLXNW
$130K
$396 ﹤0.01%
+12,500
New +$724
JWSM.WS
124
DELISTED
Jaws Mustang Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
JWSM.WS
$375 ﹤0.01%
+18,750
New +$874
SATLW icon
125
Satellogic Inc Warrant
SATLW
$92.6M
$333 ﹤0.01%
+8,333
New +$373
2 3 4
5
6

Similar funds

PC
Promethos Capital Boston, Massachusetts $372M AUM 23.19% 1-Year Est. Return
GIP
Gavilan Investment Partners Burlingame, California $372M AUM 6.04% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $372M AUM 14.96% 1-Year Est. Return
SAAM
Solus Alternative Asset Management Summit, New Jersey $372M AUM 45.33% 1-Year Est. Return
KP
Kiltearn Partners Edinburgh, United Kingdom $372M AUM 18.16% 1-Year Est. Return
TCM
Thomist Capital Management Houston, Texas $371M AUM 77.62% 1-Year Est. Return
JC
Joho Capital New York $373M AUM 18.89% 1-Year Est. Return
HPC
Highland Peak Capital Old Greenwich, Connecticut $373M AUM 80.02% 1-Year Est. Return

Blue Owl Capital Holdings's Q3 2024 Portfolio in Review

As of Q3 2024, Blue Owl Capital Holdings held 140 positions worth $518M, up 44% from $360M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Blue Owl Capital Holdings deployed $131M of net new capital in Q3 2024, opening 98 new positions and adding to 11 existing holdings. Its largest new stake was Nuveen Churchill Direct Lending: 4,039,553 shares worth $70.4M.

By sector, the portfolio is most concentrated in Healthcare at 53% of assets, down from 72% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Ultragenyx Pharmaceutical, an estimated $5.35M trimmed.

  • Blue Owl Capital Holdings's largest Q3 2024 buy was Nuveen Churchill Direct Lending: 4,039,553 shares worth $70.4M.
  • Blue Owl Capital Holdings added most to enGene Therapeutics in Q3 2024, an estimated $4.53M increase.
  • Blue Owl Capital Holdings's biggest Q3 2024 reduction was Ultragenyx Pharmaceutical, cutting an estimated $5.35M.
  • Blue Owl Capital Holdings fully exited Toast in Q3 2024, selling an estimated $8.31M.
  • Blue Owl Capital Holdings's ten largest holdings make up 65% of its $518M portfolio in Q3 2024.
  • Blue Owl Capital Holdings opened 98 new positions and closed 3 in Q3 2024.
  • Blue Owl Capital Holdings's portfolio value rose 44% quarter-over-quarter to $518M.

Based on Blue Owl Capital Holdings's 13F filing for Q3 2024, filed 14 Nov 2024.